RXi Pharmaceuticals Corporation (RXII) tumbled -5.73% or -0.11 to $1.81. It is close to 69388 shares traded, which is 68.02% compare to the average total volume 102014. The market cap of RXII is $7.70 million. The year to date change is -70.82%. The 52 week price range is from $1.81 to $7.7. Price of RXII have changed -5.88% during last week. It have changed -19.67% over last month, -41.99% over last 3 months, -62.65% over last 6 months and -67.87% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RXII is 2.35. It is 29.83% above current price. The 200-day Moving Averages for RXII is 4.07. It is 124.86% above current price. The 52-week High is 7.7. It is 325.41% from the current price. The 52-week Low is 1.81. The stock hits 52-week low today.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of RXII is 2.11 on 2018-06-15. Short % to float is 14.00%. There are some statistics of RXII. It is has market cap $7.70 million. The share outstanding is 4.26 million. The average volume is 102014. The percent of top 15 Institution holding is 54.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RXII is -182.60%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RXII is -121.02%.